Cargando…
How to Value Orphan Drugs? A Review of European Value Assessment Frameworks
Background: Decision-makers have implemented a variety of value assessment frameworks (VAFs) for orphan drugs in European jurisdictions, which has contributed to variations in access for rare disease patients. This review provides an overview of the strengths and limitations of VAFs for the reimburs...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150002/ https://www.ncbi.nlm.nih.gov/pubmed/34054519 http://dx.doi.org/10.3389/fphar.2021.631527 |